Abstract
Carbapenem-resistant Enterobacter cloacae complex (CRECC) has increasingly emerged as a major cause of healthcare-associated infections, with colistin being one of the last-resort antibiotics of treatment. Mobile colistin resistance (mcr)-9 is a member of a growing family of mcr genes and has been reported to be an inducible gene encoding an acquired phosphoethanolamine transferase. This study investigated 24 ECC strains from Chongqing, China, identifying mcr-9 in IncHI2/2A plasmids, often co-located with metallo-β-lactamase (MBL) genes. The study demonstrates that mcr-9 expression is inducible by colistin, significantly increasing resistance levels. These findings highlight the importance of effective monitoring to assess the prevalence of MBL and mcr-9 co-existing plasmids.
Introduction
The rise of Carbapenem-Resistant Enterobacterales (CRE) has forced clinicians to rely on colistin as a treatment of last resort. However, the emergence of plasmid-mediated mobilized colistin resistance (mcr) genes threatens this final line of defense. The mcr-9 gene is particularly insidious because it often appears "silent" in standard laboratory tests, with many carrying strains remaining phenotypically sensitive to colistin. This paper addresses the gap in our understanding of how mcr-9 is regulated, how it co-exists with other resistance genes like MBLs (bla<sub>NDM-1</sub>, bla<sub>IMP-4</sub>), and the mechanisms by which these "super-resistance" packages spread within hospital environments.
Methods
The authors analyzed 24 ECC strains collected from a hospital in Chongqing, China, between 2018 and 2021. Their approach combined classical microbiology with advanced genomics:
- Hybrid Sequencing: A combination of Illumina (short-read) and Oxford Nanopore (long-read) sequencing was used to achieve high-quality assemblies of complex plasmids.
- Bioinformatics: Strains were characterized using Multi-Locus Sequence Typing (MLST) and core-genome SNP analysis to track transmission dynamics.
- Conjugation Assays: Mating experiments were performed to determine if plasmids could transfer from ECC to E. coli.
- Induction & RT-qPCR: Strains were exposed to sub-inhibitory concentrations of colistin, and quantitative PCR was used to measure changes in the expression of mcr-9 and its suspected regulatory genes (qseB and qseC).
Results
Prevalence and Co-transmission of Resistance Genes
Of the 24 CRECC strains analyzed, 6 (25%) carried the mcr-9 gene. These genes were primarily located on IncHI2/2A plasmids and were frequently co-located with MBL genes. Clustering analysis revealed the distribution of these resistance determinants across different strains and sequence types.
Conjugation assays proved that these plasmids could successfully transfer both mcr-9 and MBL genes to other bacteria, such as E. coli, facilitating the simultaneous spread of multiple resistance mechanisms.
Genetic Environment and Inducible Resistance
The genetic environment of mcr-9.1 was typically composed of an IS903B-mcr-9.1-wbuC-IS26 cassette. Variations were observed, such as the presence of IS1B downstream of mcr-9.2 in certain sequences. These insertion sequences are critical for the mobility and stabilization of the resistance gene.
Crucially, the study found that mcr-9 expression is inducible. Exposure to sub-inhibitory concentrations of colistin led to a significant increase in mcr-9.2 mRNA levels (up to 8.5-fold). This induction was accompanied by an increase in the expression of the qseBC regulatory system and a dramatic jump in the Minimum Inhibitory Concentration (MIC) for colistin, from 4 mg/L to 128 mg/L.
Discussion and Conclusion
This study underscores the threat posed by inducible mcr-9 genes, which can evade detection in standard screenings but confer high-level resistance during treatment. The co-location of mcr-9 and MBL genes on mobile plasmids creates a potent "super-resistance" package. While the study is limited by a small sample size from a single location, it provides a vital basis for studying the regulatory mechanisms of mcr-9. Future research should focus on elucidating the signaling pathways between colistin exposure and the qseBC/mcr-9 axis and expanding surveillance to understand the global prevalence of these co-existing resistance plasmids.
Summary updated